pharmaceutical pollution

Adaptive responses of Gordonia alkanivorans IEGM 1277 to the action of meloxicam and its efficient biodegradation

mycolabadmin

This research demonstrates that a bacterium called Gordonia alkanivorans can break down meloxicam, a commonly used anti-inflammatory drug that pollutes our environment. The bacteria successfully converted the harmful drug into less toxic byproducts over two weeks. The study reveals how the bacteria adapted to handle the drug stress and identified the specific genes and enzymes responsible for the degradation process. These findings could lead to new biological methods for cleaning pharmaceutical pollutants from wastewater.

Pharmaceutical Pollution in Aquatic Environments: A Concise Review of Environmental Impacts and Bioremediation Systems

mycolabadmin

Medications we take for health are ending up in our water supplies in significant amounts because standard water treatment plants cannot remove them effectively. These pharmaceutical residues are harming wildlife and aquatic ecosystems, causing problems like population declines in birds, developmental issues in fish, and the spread of antibiotic resistance. Scientists are developing new bioremediation technologies, particularly using fungi and mycoremediation, to better remove these drugs from wastewater before they reach our water bodies.

Research Keyword: pharmaceutical pollution

Adaptive responses of Gordonia alkanivorans IEGM 1277 to the action of meloxicam and its efficient biodegradation

Pharmaceutical Pollution in Aquatic Environments: A Concise Review of Environmental Impacts and Bioremediation Systems